MUMFER

This brand name is authorized in Nigeria.

Active ingredients

The drug MUMFER contains one active pharmaceutical ingredient (API):

1	Iron polymaltose UNII UM5219H89V - IRON POLYMALTOSE
	Read more about Iron polymaltose

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7822	Syrup	Mumfer Syrup_ (Updates needed) SYRUP 50 mg/5 mL	Oral solution. Clear brown-coloured viscous flavoured liquid with a sweet taste. 42 Iron (Iii) Hydroxide Polymaltose A4-7822 Mumfer Syrup Iron (Iii) Hydroxide Polymaltose Vitamins Oral 50 mg/5ml Syrup Prescription Only Medicine (Pom) Glenmark Pharmaceuticals Nig Ltd M/S Glenmark Pharmaceutical Ltd India 2021-03-01 2026-02-28	01/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03A	Iron preparations	B Blood and blood forming organs → B03 Antianemic preparations
Discover more medicines within B03A

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7822